3 天前 - … review serves to underline the update on recent research … 2, epidermal growth factor
receptor tyrosine kinase (EGFR-TK) … therapy for the management of cancer. This review will …

41 天前 - … -lasting responses upon tyrosine kinase inhibitors therapy (… growth factor receptor
(EGFR)/anaplastic lymphoma kinase … The 5-years update strengthen the role of such regimen …

44 天前 - … We conducted this meta-analysis based on updated literature and research to …
tyrosine kinase inhibitors (EGFR-TKIs) as treatments for patients with non-small cell lung cancer (…

50 天前 - … Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) remain the
… patients with EGFR-mutant non-small cell lung cancer. An updated toxicity profile of EGFR-…

51 天前 - … Ongoing clinical trials are exploring novel combinations of ICIs with EGFR
monoclonal antibodies, tyrosine kinase inhibitors, and therapeutic vaccines to further improve …

54 天前 - … the only EGFR tyrosine kinase inhibitor (TKI) approved to treat patients (pts) with
EGFR-… Biomarker analyses are ongoing; updated results will be presented at time of meeting. …

90 天前 - … with tyrosine kinase … EGFR signaling in cancer cells promotes cell proliferation,
migration, invasion and survival, and these can be blocked with mAbs against the EGFR…

103 天前 - … In general, the activity of EGFR tyrosine kinase inhibitors (TKIs) does not differ … We
conducted an updated review comparing the clinical effectiveness of EGFR TKIs as a first-line …

107 天前 - … EGFR) mutation or anaplastic lymphoma kinase (ALK) rearrangement positive after
progression on tyrosine … for enrollment, and this updated abstract will highlight the feasibility …

112 天前 - … irreversible third-generation EGFR tyrosine kinase inhibitor (… for activating EGFR
mutations as well as for EGFR T790M … More recently, ADAURA results were updated and also …